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Purpose: This study describes a real-time spot weight adaptation method in spot-
scanning proton therapy for moving target or moving patient, so that the resultant dose
distribution closely matches the planned dose distribution.
Materials and methods: The method proposed in this study adapts the weight (MU) of
the delivering pencil beam to that of the target spot; it will actually hit during patient/target
motion. The target spot that a certain delivering pencil beammay hit relies on patient mon-
itoring and/or motion modeling using four-dimensional (4D) CT. After the adapted delivery,
the required total weight [Monitor Unit (MU)] for this target spot is then subtracted from
the planned value. With continuous patient motion and continuous spot scanning, the
planned doses to all target spots will eventually be all fulfilled. In a proof-of-principle test,
a lung case was presented with realistic temporal and motion parameters; the resultant
dose distribution using spot weight adaptation was compared to that without using this
method. The impact of the real-time patient/target position tracking or prediction was also
investigated.
Results: For moderate motion (i.e., mean amplitude 0.5 cm), D95% to the planning target
volume (PTV) was only 81.5% of the prescription (RX) dose; with spot weight adaptation
PTV D95% achieves 97.7% RX. For large motion amplitude (i.e., 1.5 cm), without spot
weight adaptation PTV D95% is only 42.9% of RX; with spot weight adaptation, PTV
D95% achieves 97.7% RX. Larger errors in patient/target position tracking or prediction
led to worse final target coverage; an error of 3mm or smaller in patient/target position
tracking is preferred.
Conclusion: The proposed spot weight adaptation method was able to deliver the
planned dose distribution and maintain target coverage when patient motion was
involved. The successful implementation of this method would rely on accurate monitoring
or prediction of patient/target motion.
Keywords: intensity-modulated proton therapy, interplay effect, spot scanning, spot weight adaptation,
motion
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Introduction
Spot scanning proton therapy has been shown to be a dosimetri-
cally superior radiation delivery modality in cancer treatment (1).
The ability to accurately place proton beam’s Bragg peak inside
a target is crucial to the realization of proton beam’s dosimetric
benefits. Yet multiple sources of uncertainty exist in the process
of treatment planning and treatment delivery (2–4), weakening
the potential advantage of spot scanning proton therapy. Among
these uncertainties, intra-fraction motion, especially the respira-
tory motion, is of particular concern (5), due to its less predictable
nature.
Motion management and motion mitigation strategies have
been proposed for spot scanning proton and particle beam ther-
apy. One of the most common techniques, as used in photon radi-
ation as well, is the beam gating (6, 7), which consists of irradiating
the patient only when the patient reaches a certain phase of the
breathing cycle. During gating, breathing can also be regulated
through coaching by audio or visual feedback in order to limit the
cycle’s variability (6). Motion may also be suppressed by breath-
hold or active breathing control techniques (8). Functional apnea
ormechanical ventilationmay be used under anesthesia (9). These
techniques are promising solutions but tend to be constraining for
the patient.
Other strategies not constraining the patient have been investi-
gated. Repainting (also called re-scanning) (10) consists of deliv-
ering the planned dose into several cycles instead of a single
pass. The goal is to obtain a high scanning speed by reducing
the time spent at each spot position and reduce the risk of large
localized dose discrepancies.While this technique is encouraging,
it does not take into account the patient motions during the
delivery. Four-dimensional (4D) treatment planning (11) using
acquired patient motion information to aid treatment planning
is also proposed. Beam tracking method (12, 13) calculates the
target displacement and uses this information to adapt the beam
position and beam energy to aim the planned target point in
the patient. This method is particularly promising; however, it
requires the adjustment of both the position and the energy of
the delivering pencil beam. A number of reviews and reports (5,
14, 15) provide good summaries of the existing investigative or
implemented methods.
In this work, we propose an alternative technique that only
adapts the pencil beam (spot) weights to account for the patient
intra-fraction motion. Like the beam tracking method, this
method too relies on the real-time information of target spot loca-
tion, but it allows the scanning magnets to change the beam posi-
tion and energy following a planned and quasi-continuous trajec-
tory, instead of constantly chasing the target spot. The response
time in this method is, therefore, potentially shorter; especially
considering that energy changes in beam tracking method may
be the bottleneck of effectively tracking a target.
Materials and Methods
The Principle of Spot Weight Adaptation
The overall principle of the spot weight adaptation strategy is
introduced here. At a given moment, the weight of a pencil beam
FIGURE 1 | Illustration of the planned spot delivery for a static patient.
Delivering spot positions are represented in green. Pencil beams are
represented in red. Target spots in the patient are represented in blue.
at its current energy and direction is adapted to theweight planned
for the target spot that is under the irradiation of the current beam
at this moment. The weight can be obtained from the patient and
tumor displacement at voxel levels, as well as the weight of the
pencil beam that was originally planned for this target spot.
More formally, let us consider a treatment plan, for which the
beam of one energy layer is represented by the points (bi, wi),
where i indicates the beam index, bi the beam position and wi the
corresponding planned spot weight. This plan induces the irradi-
ation of a set of respective target spot locations (Pi) in the static
patient, located at the depth of the Bragg peak. For the purpose
of implementing spot weight adaptation only, we define (Pi) as
irradiated by the delivering spot (bi,wi). The total dose to a certain
target spot (Pi) will include contributions from other delivering
spots and other energy layers. In a treatment plan generated for
a static patient, the delivering spots (bi, wi) and target spots (Pi)
have a one-to-one relationship, and therefore often not considered
separately (Figure 1).
During the treatment delivery for a static patient, the pro-
ton machine changes energy and spot position, and deliver the
planned set of pencil beams (bi, wi) one spot at a time. If the
target spots are now moving relative to the delivering spots, the
delivering spot may no longer irradiate the intended target spot.
However, the planned dose distribution may be achieved if the
target spot Pi receives the planned beam weight, wi, in terms of
Monitor Unit (MU), even if it is from a different delivering spot
bj. A simple illustration of this method is shown in Figure 2. The
motion is considered in 2D, in the plane orthogonal to the beam
direction, as a displacement vector v(t). As an example, at time
t= 2, the beam will be at position b2 and will deliver a weight w2,
following the sequence of control points in the treatment control
system as defined by the plan. However, at this moment another
target point P5 would be irradiated instead of the planned target
spot P2, and P5 would receive an irradiation corresponding to w2
instead of its planned value w5. The spot weight adaptation tech-
nique relies on the adaptation of the beam weight for delivering
spot b2, which is set to w5 instead of w2 (see Figure 3).
Frontiers in Oncology | www.frontiersin.org May 2015 | Volume 5 | Article 1192
Morel et al. Proton spot weight adaption
FIGURE 2 | Illustration of the delivery for a moving patient without spot
weight adaptation. Delivering spot positions are represented in green. Pencil
beams are represented in red. Target spots in the patient are represented in
blue. The 2D displacement vector is represented in orange.
FIGURE 3 | Illustration of the delivery for a moving patient with the
spot weight adaptation; the weight now is w5. Delivering spot positions
are represented in green. Pencil beams are represented in red. Target spots in
the patient are represented in blue. The 2D displacement vector is
represented in orange.
Implementation of Spot Weight Adaptation
Algorithm 1 represents the overall process of the delivery with
adapted spot weights.
For each field with lpos is the list of all delivering spots within a
certain energy layer, and the list lplan is built with all the delivering
spots with non-zero spots. The pencil beammoves at the planned
positions in lplan in order. At time t the beam is at position bi, and
its weight is adapted to value wk to reflect the new target spot bk.
MUs corresponding to entire or part of wk may be delivered by
ALGORITHM 1 | Algorithm of the compensated delivery. TP is the treatment
plan provided by the user. lpos is the list of all delivering spots within a certain energy
layer, including those with zero weights based on the plan. lplan is the list of the
delivering spots with non-zero spots.
begin
foreach Gantry angle do
foreach Energy level do
Build lpos the list of all the delivering spots;
//Note: if margin is used, include in lpos the margin beam positions with
weight= 0 if margin is used. See description later about margin.
Build lplan the list of all the delivering spots with weights >0;
while lplan is not empty do
foreach Delivering spot bi in lpos do
Get the patient displacement vector v(t) and target spot (bk , wk )
if available
//Obtained from the motion monitoring system and/or motion
modeling; see Motion Information section below.
//wk being the weight associated to bk in treatment plan
Irradiate the target spot with (bi , wk ) or part of wk ;
Update lplan: remove wk or part of wk from bk ;
return;
FIGURE 4 | Illustration of the delivery for a moving patient with spot
weight adaptation where a margin is added around the planned
delivering spots. Planned delivering spots are represented in green. Beams
are represented in red. Target spots in the patient are represented in blue. The
patient displacement vector is represented in orange.
bi, and wk is updated to become its remaining weight or zero for
bk. The beam then moves to the next position. To fully cover the
target spots, Algorithm 1 needs to be repeated multiple times, i.e.,
re-scanning is necessary; otherwise the planned target spots may
not be fully delivered. The number of re-scans can be reduced by
adding amargin around the planned spot positions (see Figure 4).
The size of themargin can be adjusted by user to its optimal value,
which may depend on the extent and speed of patient motion.
Motion Information
Implementing the spot weight adaptation algorithm requires
knowing or predicting the patient and target position Pi(t) at each
moment of beam delivery. This is the same process as what is
performed in the beam tracking method (12). In practice, this can
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FIGURE 5 | The SBRT lung testing case with the delineation of the tumor and the organ-at-risk.
TABLE 1 |Motion and monitoring settings in different tests for the testing case.
Test No. Intra-fraction
motion
Motion Spot weight
adaptation?
Motion monitoring
error [σx, σy, σz] in cm
Mean
amplitude
[x, y, z] in cm
Amplitude
Gaussian noise
[σx, σy, σz] in cm
Mean cycle
period
[x, y, z] in s
Cycle
period Gaussian
noise [σx, σy, σz] in s
1 No – – – – – –
2 Yes [0.5, 0.5, 0] [0.1,0.1, 0] [4, 4, 0] [0.8, 0.8, 0] No –
3 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] No –
4 Yes [0.5, 0.5, 0] [0.1,0.1, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [0, 0, 0]
5 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [0, 0, 0]
6 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [0.3, 0.3, 0]
7 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [0.75, 0.75, 0]
8 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [1.5, 1.5, 0]
It is assumed that patient moves in sinusoidal patterns in X and Y axes independently (X–Y plane is perpendicular to the posterior beam’s direction), with Gaussian noise existing for
mean amplitudes and cycle periods. Noise is assumed to be 20% of the mean value (16). It is further assumed that a real-time patient monitoring system exists, but with Gaussian error
in its detected signals. Test 1 is the static plan; Test 2 is the test with moderate motion without spot weight adaptation, and Test 4 is the test with moderate motion with spot weight
adaptation. Test 3 is the test with large motion but no spot weight adaptation; Tests 5–8 are tests with large motion and with spot weight adaptation but different levels of error in motion
monitoring.
FIGURE 6 | Dose distributions for testing case in static situation [(A), Test 1], in moderate moving situation without spot weight adaptation [(B), Test
2], and in moderate moving situation with spot weight adaptation [(C), Test 4]. Dose color map is relative to max dose in the static situation.
be achieved with reasonable accuracy in two ways: (1) by mod-
eling patient motion through 4DCT acquired before treatment
planning and then relating patient motion to respiratory phase
observables during treatment; (2) or bymonitoring patientmotion
during treatment in real time through devices such as Calypso®
system (Varian Medical Systems, Palo Alto, CA, USA). The spot
weight adaptation method itself does not rely on any specific
method to supply patient motion information. In this work for the
purpose of proof-of-principle testing, a motion model is created
for the testing case patient, and a certain patient monitoring
system is assumed to monitor patient motion in real-time, with
realistic time delay and measurement noise included.
Motion Simulation and Dose Computation
Motion simulation and dose computation were performed in
in-house software named Motion Simulator for Proton Therapy
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(MSPT) (http://code.google.com/p/mspt/). MSPT is an open-
source treatment planning software that enables 4D dose compu-
tation. MSPT can import patient CT, structure, and spot scanning
treatment plan inDICOMRT format. It can simulate user-defined
motion pattern on the patient dataset on a voxel-by-voxel basis,
and compute delivered dose in each temporal moment consid-
ering the temporal model for the beam delivery system, using
analytical dose computation algorithm. It then sums the dose for
each patient voxel along the time axis and produces the total dose
distribution for the patient. A detailed description about MSPT
and its validation has been published elsewhere (Morel et al. under
review). The weight adaptation algorithm was implemented in
MSPT for the test casing described below.
A Testing Case
To evaluate the compensation method, we perform motion sim-
ulation and dose computation on a SBRT lung case shown in
Figure 5. Motions of moderate amplitude (0.5 cm in any dimen-
sion) and large amplitude (1.5 cm in any dimension) are simu-
lated respectively. Different levels of error for motion monitoring
are also introduced. The simulation settings are summarized in
Table 1.
FIGURE 7 | Dose volume histogram (DVH) for testing case in static
situation (Test 1), in moderate moving situation without spot weight
adaptation (Test 2), and in moderate moving situation with spot weight
adaptation (Test 4). 95% of RX dose and 95% of planning target volume
(PTV) are marked.
Dose distribution color map and dose volume histogram
(DVH) are used in evaluating the delivered dose distributions in
different tests. To evaluate the quality of the delivered dose distri-
bution, we consider the following criterion to evaluate whether
the desired tumor coverage is maintained with patient motion:
if 95% of the tumor volume receives 95% of the prescribed dose
Rx (D95% 95% Rx) in one fraction, then we consider target
coverage is maintained in this fraction. In our situation the dose
distribution used as a reference is the planned static delivery.
Therefore, we will assume that the dose prescription Rx is the
tumor D95% in the planned static dose distribution.
Patient imaging data used in this study are from consented
patients and approved by the Institutional Review Board (IRB) at
the University of Iowa (IRB #201211805).
Results
Spot Weight Adaptation for Moderate Amplitude
Motions
The effect of spot weight adaptation for amoderate motion ampli-
tude (i.e., 0.5 cm) can be seen from the comparison between Tests
1, 2, and 4 (see Table 1 for test settings). Figure 6 shows the dose
distribution color map of the three tests obtained near the center
of the tumor. Figure 7 shows the DVH for the three tests.
From Figure 6, we can observe that with moderate motion (i.e.,
mean amplitude 0.5 cm) the dose distributions of the static and
the spot-weight-adapted delivery are close, whereas dose hetero-
geneities are visible in the tumor in the case of the non-adapted
delivery (Test 2, Figure 6B). Based on the DVH in Figure 7, PTV
coverage is degraded in Test 2 without spot weight adaptation,
where PTV D95% is only 81.5% of RX; but with spot weight
adaptation, PTVD95% achieves 97.7%RX. The hot spot in the non-
adapted Test 2 is also higher than the planned value. OAR dose
in the non-adapted Test 2 is also higher, though not significantly
worse than planned value.
Spot Weight Adaptation for Large Amplitude
Motions
The effect of the spot weight adapted delivery for a large motion
amplitude (i.e., 1.5 cm) can be seen from the comparison between
Test 1, 3, and 5 (see Table 1 for the settings). Figure 8 shows the
FIGURE 8 | Dose distributions for testing case in static situation [(A), Test 1], in large moving situation without spot weight adaptation [(B), Test 3],
and in large moving situation with spot weight adaptation [(C), Test 5]. Dose color map is relative to max dose in the static situation.
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dose distribution color map of the three tests obtained near the
center of the tumor. Figure 9 shows the DVH for the three tests.
From Figure 8, we can observe that with large motion (i.e.,
mean amplitude 1.5 cm) the dose distributions of the static and
the spot-weight-adapted delivery are close, whereas dose het-
erogeneities are very obvious in the tumor in the case of the
non-adapted delivery (Test 3, Figure 8B). Based on the DVH in
Figure 9, PTV coverage is degraded in Test 3 without spot weight
adaptation, where PTV D95% is only 42.9% of RX; but with spot
weight adaptation, PTVD95% achieves 97.7%RX. With spot weight
adaptation, the delivered dose to OARs significantly deteriorated
from the planned values; while with spot weight adaptation,
FIGURE 9 | Dose volume histogram (DVH) for testing case in static
situation (Test 1), in large moving situation without spot weight
adaptation (Test 3), and in moving situation with spot weight
adaptation (Test 5). 95% of RX dose and 95% of planning target volume
(PTV) are marked.
delivered dose is very close to planned values, as shown from the
DVH in Figure 9.
The Impact of the Monitoring System Accuracy
In the evaluations for spot weight adaptation with moderate
and large motion (Test 2–5), an ideal patient monitoring system
is assumed. In reality, patient motion information as an input
to the spot weight adaptation algorithm should always contain
errors. While both spatial and temporal errors can be present,
only the impact of spatial errors is studied here, because the
temporal error in detecting a current position of target spot and
the delay of beam delivering can still be reflected in the error of
target spot’s spatial location. Gaussian errors of three different
levels of standard deviations were added: Tests 5 (σ= 0 cm), 6
(σ= 0.3 cm), 7 (σ= 0.75 cm), and 8 (σ= 1.5 cm). Table 1 has the
summary of the settings for these tests. Figure 10 shows the dose
distributions for Tests 5–8, and Figure 11 shows the DVH for
Tests 5–8.
From both Figures 10 and 11, we can see that the accuracy of
the monitoring system has an impact of the quality of the final
dose distribution. PTV D95% for Gaussian error of 0.3, 0.75, and
1.5 cm are 91.2% RX, 73.1% RX, and 55.7% RX, respectively.
Discussion and Conclusion
When moderate (mean amplitude 0.5 cm) or large motion (mean
amplitude 1.5 cm) is present in the testing case, delivering the plan
without any adaptation deteriorated PTV coverage (Test 2 and
Test 3, with PTV D95% at only 81.5% RX and 42.9% RX, respec-
tively). This study proposed amethod to adapt spot weight during
delivery, with patient motion information as input. With spot
weight adaptation, PTV coverage was able to achieve 97.7%RX for
FIGURE 10 | Dose distributions for spot-weighted-adapted delivery with large motion, with different patient monitoring errors: σ= 0cm (A), 0.3 cm
(B), 0.75 cm (C), 1.5 cm (D). Dose color map is relative to max dose in the static situation.
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FIGURE 11 | Dose volume histogram for spot-weighted-adapted
delivery with large motion, with different levels of patient monitoring
errors.
moderate and large motion (Test 3 and Test 5), which is clinically
acceptable.
The proof-of-principle example in this study did not include
change in radiological depth, which would require spot weight
adaptation across energy layers. The spot weight adaptation
method in principle can adapt weight across energy layers, i.e.,
the method will look for the correct weight if the energy layer is
different. Similar to the lateral spot margins as shown in Figure 4,
an energy margin with spots of zero initial weight can be added.
The zero-weight spots are to allow the delivering beam to move
to that energy/place first, and then choose its MU based on the
currently target spot. Re-scanning will be necessary in order to
cover all spots and all energy layers. The number of re-scanning
is likely smaller when the margin is larger. Since energy layer
switch is usually in the order of seconds for spot scanning proton
therapy, the number of re-scanning is important in determining
the total treatment time. The relation between the number of re-
scans and the size of the energy and lateral margins is currently
being investigated and will be reported in future.
While the results also show the impact of the patient motion
modeling and monitoring accuracy in spot weight adaptation
method, just as in beam tracking method (12), this study shows
that the spot weight adaptation itself is a promising strategy in
mitigating the impact of patient motion during spot scanning
proton therapy.
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